196 related articles for article (PubMed ID: 9628873)
1. Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation.
Engel K; Kotlyarov A; Gaestel M
EMBO J; 1998 Jun; 17(12):3363-71. PubMed ID: 9628873
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of serine 271 on 5-lipoxygenase and its role in nuclear export.
Flamand N; Luo M; Peters-Golden M; Brock TG
J Biol Chem; 2009 Jan; 284(1):306-313. PubMed ID: 18978352
[TBL] [Abstract][Full Text] [Related]
3. Nucleocytoplasmic shuttling of Pak5 regulates its antiapoptotic properties.
Cotteret S; Chernoff J
Mol Cell Biol; 2006 Apr; 26(8):3215-30. PubMed ID: 16581795
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of MAPK-activated protein kinase 2:p38 assembly.
White A; Pargellis CA; Studts JM; Werneburg BG; Farmer BT
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6353-8. PubMed ID: 17395714
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C phosphorylates ribosomal protein S6 kinase betaII and regulates its subcellular localization.
Valovka T; Verdier F; Cramer R; Zhyvoloup A; Fenton T; Rebholz H; Wang ML; Gzhegotsky M; Lutsyk A; Matsuka G; Filonenko V; Wang L; Proud CG; Parker PJ; Gout IT
Mol Cell Biol; 2003 Feb; 23(3):852-63. PubMed ID: 12529391
[TBL] [Abstract][Full Text] [Related]
6. Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells.
Nie L; Wang YN; Hsu JM; Hou J; Chu YY; Chan LC; Huo L; Wei Y; Deng R; Tang J; Hsu YH; Ko HW; Lim SO; Huang K; Chen MK; Chiu TJ; Cheng CC; Fang YF; Li CW; Goverdhan A; Wu HJ; Lee CC; Wang WL; Hsu J; Chiao P; Wang SC; Hung MC
Am J Cancer Res; 2023; 13(4):1209-1239. PubMed ID: 37168336
[TBL] [Abstract][Full Text] [Related]
7. MAPKAP Kinase-2 phosphorylation of PABPC1 controls its interaction with 14-3-3 proteins after DNA damage: A combined kinase and protein array approach.
Stehn JR; Floyd SR; Wilker EW; Reinhardt HC; Clarke SM; Huang Q; Polakiewicz RD; Sonenberg N; Kong YW; Yaffe MB
Front Mol Biosci; 2023; 10():1148933. PubMed ID: 37091863
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity.
Fujino A; Fukushima K; Kubota T; Kosugi T; Takimoto-Kamimura M
J Synchrotron Radiat; 2013 Nov; 20(Pt 6):905-9. PubMed ID: 24121337
[TBL] [Abstract][Full Text] [Related]
9. MK2 nonenzymatically promotes nuclear translocation of caspase-3 and resultant apoptosis.
Del Rosario O; Suresh K; Kallem M; Singh G; Shah A; Zheng L; Yun X; Philip NM; Putcha N; McClure MB; Jiang H; D'Alessio F; Srivastava M; Bera A; Shimoda LA; Merchant M; Rane MJ; Machamer CE; Mock J; Hagan R; Koch AL; Punjabi NM; Kolb TM; Damarla M
Am J Physiol Lung Cell Mol Physiol; 2023 May; 324(5):L700-L711. PubMed ID: 36976920
[TBL] [Abstract][Full Text] [Related]
10. Cross-species transcriptomic signatures predict response to MK2 inhibition in mouse models of chronic inflammation.
Suarez-Lopez L; Shui B; Brubaker DK; Hill M; Bergendorf A; Changelian PS; Laguna A; Starchenko A; Lauffenburger DA; Haigis KM
iScience; 2021 Dec; 24(12):103406. PubMed ID: 34849469
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic leukemia protein targets MK2 to promote cytotoxicity.
Chen IT; Chen HC; Lo YH; Lai PY; Hsieh FY; Wu YH; Shih HM; Lai MZ
EMBO Rep; 2021 Dec; 22(12):e52254. PubMed ID: 34633746
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic MK2 inhibition blocks pathological vascular smooth muscle cell phenotype switch.
Tierney JW; Evans BC; Cheung-Flynn J; Wang B; Colazo JM; Polcz ME; Cook RS; Brophy CM; Duvall CL
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622803
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer.
Morgan D; Berggren KL; Spiess CD; Smith HM; Tejwani A; Weir SJ; Lominska CE; Thomas SM; Gan GN
Mol Carcinog; 2022 Feb; 61(2):173-199. PubMed ID: 34559922
[TBL] [Abstract][Full Text] [Related]
14. MAPKAP Kinase-2 Drives Expression of Angiogenic Factors by Tumor-Associated Macrophages in a Model of Inflammation-Induced Colon Cancer.
Suarez-Lopez L; Kong YW; Sriram G; Patterson JC; Rosenberg S; Morandell S; Haigis KM; Yaffe MB
Front Immunol; 2020; 11():607891. PubMed ID: 33708191
[TBL] [Abstract][Full Text] [Related]
15. The functional landscape of Golgi membrane protein 1 (GOLM1) phosphoproteome reveal GOLM1 regulating P53 that promotes malignancy.
Song Q; He X; Xiong Y; Wang J; Zhang L; Leung EL; Li G
Cell Death Discov; 2021 Mar; 7(1):42. PubMed ID: 33649292
[TBL] [Abstract][Full Text] [Related]
16. MAP Kinase-Mediated Activation of RSK1 and MK2 Substrate Kinases.
Sok P; Gógl G; Kumar GS; Alexa A; Singh N; Kirsch K; Sebő A; Drahos L; Gáspári Z; Peti W; Reményi A
Structure; 2020 Oct; 28(10):1101-1113.e5. PubMed ID: 32649858
[TBL] [Abstract][Full Text] [Related]
17. Recognition of nuclear export signals by CRM1 carrying the oncogenic E571K mutation.
Baumhardt JM; Walker JS; Lee Y; Shakya B; Brautigam CA; Lapalombella R; Grishin N; Chook YM
Mol Biol Cell; 2020 Aug; 31(17):1879-1891. PubMed ID: 32520643
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor death-associated protein kinase 1 inhibits necroptosis by p38 MAPK activation.
Wu YH; Chou TF; Young L; Hsieh FY; Pan HY; Mo ST; Brown SB; Chen RH; Kimchi A; Lai MZ
Cell Death Dis; 2020 May; 11(5):305. PubMed ID: 32366830
[TBL] [Abstract][Full Text] [Related]
19. MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression.
Soni S; Anand P; Padwad YS
J Exp Clin Cancer Res; 2019 Mar; 38(1):121. PubMed ID: 30850014
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
